Interstitial Lung Disease in Practice: Screening, Treatment Strategies, and Multidisciplinary Collaboration

EP. 1: Closing the Gap: Screening and Treatment Ownership in CTD-Associated ILD

April 17th 2026

Experts discuss CTD-ILD guidance and nerandomilast reshape screening, progression monitoring, and multidisciplinary treatment.

EP. 2: The Evolving Role of the Rheumatologist in ILD, With Viraj Shah, MD

ByViraj Shah, MD

July 21st 2026

Shah shares conversations from a recent clinical forum on best practices and collaboration for interstitial lung disease management.

Jessica Golden, MD: Examining SARD-ILD Screening and Treatment Best Practices

EP. 3: Jessica Gordan, MD: Examining SARD-ILD Screening and Treatment Best Practices

ByJessica Gordan, MD

October 26th 2026

Jessica Gordon, MD, MS, and New York rheumatologists discuss who to screen for ILD, how to monitor without overimaging, and when to add antifibrotics.

Interstitial Lung Disease in Practice: Screening, Treatment Strategies, and Multidisciplinary Collaboration

EP. 1: Closing the Gap: Screening and Treatment Ownership in CTD-Associated ILD

EP. 2: The Evolving Role of the Rheumatologist in ILD, With Viraj Shah, MD

EP. 3: Jessica Gordan, MD: Examining SARD-ILD Screening and Treatment Best Practices

Trending on Rheumatology Live

Nipocalimab, Telitacicept, and the Sjögren’s Disease Pipeline

Dazodalibep Eases Sjögren’s Dryness via CD40L Blockade: Ghaith Noaiseh, MD

Dazodalibep Lowers Sjögren’s Disease Activity: Ghaith Noaiseh, MD

INDIGO: Obexelimab Sustains IgG4-RD Flare Control, With John Stone, MD, MPH

Selecting Sjögren’s Patients for Ianalumab and Weighing Safety